Cargando…

Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma

In the current study, we aimed to investigate the expression of the five microsomal signal peptidase complex (SPC) subunit genes (SEC11A, SEC11C, SPCS1, SPCS2, and SPCS3) in head and neck squamous cell carcinoma (HNSC) and to explore their prognostic value. Data from the HNSC subset of The Cancer Ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Chunmei, Fan, Jiangang, He, Gang, Dong, Chuan, Zhou, Shijie, Zheng, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162331/ https://www.ncbi.nlm.nih.gov/pubmed/35653344 http://dx.doi.org/10.1371/journal.pone.0269166

Ejemplares similares

High SEC61G expression predicts poor prognosis in patients with Head and Neck Squamous Cell Carcinomas
por: Liang, Leifeng, et al.
Publicado: (2021)

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Li, Jing, et al.
Publicado: (2022)

SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma
por: Shi, Yanan, et al.
Publicado: (2021)

The β Subunit of the Sec61 Complex Facilitates Cotranslational Protein Transport and Interacts with the Signal Peptidase during Translocation
por: Kalies, Kai-Uwe, et al.
Publicado: (1998)

Alterations of GPI transamidase subunits in head and neck squamous carcinoma
por: Jiang, Wei-Wen, et al.
Publicado: (2007)

Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma
por: WEMMERT, SILKE, et al.
Publicado: (2016)

SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2021)

Corrigendum to “SEC11A contributes to tumour progression of head and neck squamous cell carcinoma” [Heliyon 9(4) (April 2023) e14958]()
por: Shen, Hailong, et al.
Publicado: (2023)

Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas
por: Gasparotto, Daniela, et al.
Publicado: (2011)

Head and Neck Squamous Cell Carcinoma in Western Uganda: Disease of Uncertainty and Poor Prognosis
por: Nabukenya, Jamilah, et al.
Publicado: (2018)

Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma
por: Ahmadi, Mohsen, et al.
Publicado: (2021)

LAT1 is associated with poor prognosis and radioresistance in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2023)

Regulation of exocytosis by the exocyst subunit Sec6 and the SM protein Sec1
por: Morgera, Francesca, et al.
Publicado: (2012)

Large-Scale Evolutionary Analyses on SecB Subunits of Bacterial Sec System
por: Yan, Shaomin, et al.
Publicado: (2015)

A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients
por: Xu, Yuzi, et al.
Publicado: (2021)

Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Ram, Ashwin Jaikumar, et al.
Publicado: (2020)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Fu, Ling-ling, et al.
Publicado: (2022)

FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma
por: Liao, Qingyun, et al.
Publicado: (2023)

MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma
por: Jia, Shiheng, et al.
Publicado: (2020)

SEC61 translocon subunit gamma enhances low-dose cisplatin-induced cancer-stem cell properties of head and neck squamous cell carcinoma via enhancing Ca(2+)-mediated autophagy
por: Bu, Xiangbin, et al.
Publicado: (2023)

PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer
por: Wigfield, S M, et al.
Publicado: (2008)

Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma
por: Li, Guo, et al.
Publicado: (2015)

Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma
por: Hollows, Robert, et al.
Publicado: (2018)

High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma
por: Cui, Kun, et al.
Publicado: (2022)

Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma
por: Fu, Ling-ling, et al.
Publicado: (2022)

Overexpression of fatty acid desaturase 3 predicts poor prognosis in head and neck squamous cell carcinoma
por: Su, Kuiwei, et al.
Publicado: (2022)

Relationships of Ferroptosis and Pyroptosis-Related Genes with Clinical Prognosis and Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yu, Jiangang, et al.
Publicado: (2022)

Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas
por: Bochen, Florian, et al.
Publicado: (2016)

Fascin upregulation in primary head and neck squamous cell carcinoma is associated with lymphatic metastasis
por: PAPASPYROU, KONSTANTINOS, et al.
Publicado: (2014)

Sec12 heads for the exits
por: Leslie, Mitch
Publicado: (2014)

KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck
por: Huang, Donghai, et al.
Publicado: (2018)

High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma
por: Li, Bo, et al.
Publicado: (2019)

Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

CD8(+) T-cell exhaustion in the tumor microenvironment of head and neck squamous cell carcinoma determines poor prognosis
por: Zhang, Yijian, et al.
Publicado: (2022)

Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma
por: Yang, Xueming, et al.
Publicado: (2023)

Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas
por: Huang, Yongsheng, et al.
Publicado: (2022)

Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients
por: Schrader, Carola H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_afb847fp0kj8vqevvm6rhgtgn9